Payoneer adopts change-in-control severance plan for executives, excluding CEO and CFO
Payoneer's Compensation Committee adopted an Executive Change in Control Severance Plan on November 28, 2025, covering executives including named executive officers. The plan provides cash, health coverage and equity vesting if a participant is terminated without cause or resigns for good reason after a change in control, and the CEO and CFO will not participate.
Key points
- Plan adopted by the Compensation Committee on November 28, 2025; participation requires a participation agreement and a separation and release agreement.
- Benefits include a lump sum equal to annual base salary plus annual target bonus, and up to twelve months of medical and dental coverage at active employee rates.
- Time-vesting equity awards vest immediately; performance awards follow their award agreements, with time-vesting deemed satisfied at termination.
- The CEO and CFO will not participate and keep existing severance rights under their employment agreements.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 03, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.